Core Viewpoint - The company announces the resignation of its board secretary, Ge Jingbo, due to personal reasons, and he will no longer hold any position within the company [2][3]. Group 1: Resignation Details - Ge Jingbo submitted a written resignation report to the board, which is effective upon delivery to the board [3]. - The company confirms that Ge Jingbo has completed the handover of his responsibilities, and his resignation will not affect the normal operations of the company [3]. Group 2: Impact on the Company - The company will promptly complete the selection of a new board secretary in accordance with relevant regulations and its articles of association [3]. - Until a new board secretary is appointed, the chairman, Yuan Jianhua, will act in this capacity [3]. - Ge Jingbo did not hold any shares in the company during his tenure and was recognized for his diligent work in governance, information disclosure, and investor relations [3].

通过天眼查大数据分析，广州洁特生物过滤股份有限公司共对外投资了14家企业，参与招投标项目182 次，知识产权方面有商标信息79条，专利信息266条，此外企业还拥有行政许可67个。 来源：金融界 金融界消息 截至2025年8月14日收盘，洁特生物（688026）报收于19.77元，下跌5.86%，换手率 5.92%，成交量8.30万手，成交金额1.68亿元。 资金流向方面，今日主力资金净流出3352.19万元，占比成交额19.96%。其中，超大单净流出1010.96万 元、占成交额6.02%，大单净流出2341.23万元、占成交额13.94%，中单净流出流入842.18万元、占成交 额5.02%，小单净流入2510.02万元、占成交额14.95%。 洁特生物最新一期业绩显示，截至2025一季报，公司营业总收入1.24亿元、同比增长26.00%，归属净利 润1646.23万元，同比增长101.29%，扣非净利润1564.92万元，同比增长269.23%，流动比率8.034、速动 比率6.628、资产负债率28.76%。 天眼查商业履历信息显示，广州洁特生物过滤股份有限公司，成立于2001年，位于广州市，是一家以从 ...

Core Viewpoint - The company has decided not to adjust the conversion price of its convertible bonds, despite triggering the downward adjustment clause due to stock price performance [2][7]. Group 1: Convertible Bond Details - The company issued 4.4 million convertible bonds at a face value of 100 RMB each, raising a total of 440 million RMB [3]. - The initial conversion price was set at 48.23 RMB per share, which was adjusted to 48.09 RMB on June 6, 2023, and further adjusted to 48.02 RMB on July 4, 2024, and to 47.95 RMB on July 2, 2025 [4]. - The downward adjustment clause is triggered when the stock price is below 85% of the conversion price for at least 15 out of 30 consecutive trading days [5]. Group 2: Board Decision - The board of directors convened on August 1, 2025, and unanimously agreed not to adjust the conversion price, with all related directors abstaining from the vote [8][9]. - The decision will remain in effect for three months, until November 1, 2025, during which time the company will not propose any downward adjustment even if the clause is triggered again [7][9].

Summary of Key Points Core Viewpoint - The announcement details the completion of a share reduction plan by a major shareholder of Guangzhou Jiete Biological Filtration Co., Ltd, indicating a strategic move in the company's ownership structure and potential implications for future governance and investment. Group 1: Shareholder Information - The shareholder, Guangzhou Luogang District Huizi Investment Management Partnership (Limited Partnership), held 1,396,950 shares, representing 1.00% of the company's total share capital prior to the reduction plan [2]. - The shares were acquired before the company's IPO and through capital reserve conversion, with the lock-up period lifted on January 30, 2023, allowing for trading [2]. Group 2: Reduction Plan Implementation - The shareholder planned to reduce holdings by up to 186,315 shares, which is 0.1327% of the total share capital, through centralized bidding [3]. - As of July 10, 2025, the shareholder successfully reduced their holdings by 186,315 shares, fully aligning with the previously disclosed reduction plan [3][4]. - The reduction was confirmed to have met the planned minimum reduction quantity, and the plan was not terminated early [4].

Summary of Key Points Core Viewpoint - The company has established a special account for the management and use of raised funds, ensuring investor protection and compliance with regulatory requirements [1][2][3]. Fundraising Basic Information - The company issued 4.4 million convertible bonds at a face value of 100 RMB each, raising a total of 440 million RMB, which has been verified by Tianjian Accounting Firm [1]. Special Account Establishment - A special account for raised funds has been set up to temporarily supplement working capital, with a limit of 200 million RMB, effective for up to 12 months from December 30, 2024 [2][3]. Three-Party Supervision Agreement - The company signed a three-party supervision agreement with the underwriter and the bank to regulate the management of raised funds, ensuring they are used solely for designated purposes [3][4]. Regulatory Compliance - The agreement aligns with relevant laws and regulations, including the Shanghai Stock Exchange's self-regulatory guidelines, to protect investor rights [4][5]. Monitoring and Reporting - The underwriter is responsible for ongoing supervision of the fund usage, including site investigations and documentation requests, to ensure compliance with the agreement [4][5].

Group 1 - The company's credit rating remains at A+ with a stable outlook for both the company and its convertible bonds [1][2] - The credit rating agency Zhongzheng Pengyuan conducted a follow-up credit rating for the company on June 26, 2025, confirming the ratings [2] - The previous credit rating was also A+ with a stable outlook, assessed on June 26, 2024 [1][2] Group 2 - The follow-up rating report was published on the Shanghai Stock Exchange website on the same day as the rating [2]

Core Viewpoint - The company, Guangzhou Jiete Biological Filtration Co., Ltd., is implementing a differentiated dividend distribution plan for the year 2024, which is based on the number of shares available after accounting for shares repurchased and held in a special account [1][2][5]. Group 1: Reasons for Differentiated Dividend - The differentiated dividend is a result of the company's decision to repurchase shares using its own or raised funds, with a total repurchase amount between RMB 20 million and RMB 40 million, and a maximum repurchase price of RMB 19.36 per share [1][2]. - The repurchased shares will not participate in profit distribution, leading to the need for a differentiated dividend distribution plan [2][3]. Group 2: Dividend Distribution Plan - The company plans to distribute a cash dividend of RMB 0.73 per 10 shares (including tax) to all shareholders based on the total share capital minus the repurchased shares [2][3]. - The actual number of shares participating in the distribution is 137,632,306 shares, calculated from the total share capital of 140,363,220 shares after deducting the repurchased shares [3][4]. Group 3: Calculation Basis for Differentiated Dividend - The cash dividend per share is calculated based on the adjusted total share capital, and the reference price for ex-dividend trading is determined using the formula: (previous closing price - cash dividend) / (1 + change in circulating shares ratio) [3][4]. - The impact of the differentiated dividend on the ex-dividend reference price is minimal, with an absolute value change of less than 1% [4]. Group 4: Verification Opinion - The sponsoring institution, Minsheng Securities, confirms that the differentiated dividend distribution complies with relevant laws and regulations, ensuring no harm to the interests of the company and all shareholders [5][6].

Core Viewpoint - The company announced an adjustment to the conversion price of its convertible bonds due to the implementation of the 2024 annual profit distribution plan, which includes a cash dividend of 0.73 yuan per 10 shares [1][2][4]. Summary by Sections Announcement of Adjustment - The conversion price of "洁特转债" will be adjusted from 48.02 yuan per share to 47.95 yuan per share, effective from July 2, 2025 [1][4]. - The trading of "洁特转债" will be suspended from June 24, 2025, until the equity registration date of July 1, 2025, and will resume on July 2, 2025 [1][4]. Basis for Adjustment - The adjustment is based on the resolution passed at the 2024 annual general meeting, which approved a cash dividend distribution of 0.73 yuan per 10 shares, with no stock increases or bonus shares [1][2][4]. - The total number of shares after excluding repurchased shares is 140,363,220, with 2,730,914 shares repurchased [4]. Calculation of Adjustment - The cash dividend per share is calculated as approximately 0.0716 yuan, leading to the new conversion price being calculated as follows: P1 = P0 - D, where P0 is the old conversion price and D is the cash dividend [4]. - The formula for adjusting the conversion price is provided, detailing how various corporate actions affect the conversion price [2][4]. Other Information - Investors seeking more details about "洁特转债" can refer to the company's prospectus published on June 24, 2022 [5].

证券代码：688026 证券简称：洁特生物 公告编号：2025-035 转债代码：118010 转债简称：洁特转债 广州洁特生物过滤股份有限公司 关于"洁特转债"2025 年付息的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ? 可转债付息债权登记日：2025 年 6 月 27 日 ? 可转债除息日：2025 年 6 月 30 日（因 2025 年 6 月 28 日为非交易日， 除息日顺延至 2025 年 6 月 30 日） ? 可转债兑息日：2025 年 6 月 30 日（因 2025 年 6 月 28 日为非交易日， 兑息日顺延至 2025 年 6 月 30 日） 广州洁特生物过滤股份有限公司（以下简称"公司"）于 2022 年 6 月 28 日 发行的可转换公司债券将于 2025 年 6 月 30 日开始支付自 2024 年 6 月 28 日至 特定对象发行可转换公司债券募集说明书》 （以下简称"《募集说明书》"）有关条 款的规定，现将有关事项公告如下： 一、可转债发行上市概况 二、本次付息方 ...

Core Viewpoint - The announcement from Jiet Bio (688026.SH) regarding a share reduction plan by its shareholder, Guangzhou Luogang District Huizi Investment Management Partnership, indicates a planned reduction of up to 186,315 shares, representing no more than 0.1327% of the company's total share capital, due to the shareholder's personal funding needs [1][2]. Group 1: Shareholder Reduction Plan - The shareholder, Huizi Investment, plans to reduce its holdings through centralized bidding from July 2, 2025, to October 1, 2025 [1][2]. - The total shares held by Huizi Investment before the reduction is 1,396,950 shares, which accounts for 1.00% of the company's total share capital [2]. - The shares intended for reduction were acquired before the IPO and through capital reserve conversion [2]. Group 2: Company Background - Jiet Bio was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on January 22, 2020, with an issuance of 25 million shares at a price of 16.49 yuan per share [3]. - The company raised a total of 412.25 million yuan from its initial public offering, with a net amount of 379.41 million yuan after deducting issuance costs [3][5]. - The company has conducted two fundraising activities, totaling 852.25 million yuan [5]. Group 3: Financial Information - The company issued convertible bonds approved by the China Securities Regulatory Commission, raising a total of 440 million yuan, with a net amount of approximately 432.49 million yuan after expenses [4]. - The company distributed cash dividends of 0.6 yuan per share and increased its capital stock by 0.4 shares per share based on a total share capital of 100 million shares prior to the distribution [6].